SCHEMBL10639232

SCHEMBL10639232

Cc1ccc(C(=O)C(C(=O)OCc2ccccc2)N2CCCC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 7/20 0.49
SLC6A2 P23975 6/20 0.49
SLC6A4 P31645 4/20 0.49
RAB9A P51151 2/20 0.45
CHRM2 P08172 1/20 0.44
ADRA2B P18089 1/20 0.44
DRD3 P35462 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
MAPT P10636 1/20 0.44
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
HPGD P15428 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10642077 0.91 SLC6A2 (0.49) SLC6A3SLC6A2RAB9AMAPTALDH1A1
SCHEMBL10641121 0.88 SLC6A2 (0.53) SLC6A3SLC6A2SLC6A4RAB9AMAPT
SCHEMBL10640779 0.88 NTSR1 (0.47) SLC6A3SLC6A2RAB9AMAPTALDH1A1
SCHEMBL10642576 0.84 SLC6A4 (0.51) SLC6A4RAB9ASIGMAR1HRH3MAPT
SCHEMBL10642942 0.84 SLC6A3 (0.59) SLC6A3SLC6A2SLC6A4RAB9ACHRM2
SCHEMBL10636817 0.82 SLC6A3 (0.48) SLC6A3SLC6A2SLC6A4CHRM2ADRA2B
SCHEMBL10639658 0.82 SLC6A3 (0.53) SLC6A3SLC6A2SLC6A4RAB9AHRH3
SCHEMBL10637337 0.81 SLC6A3 (0.57) SLC6A3SLC6A2SLC6A4RAB9ACHRM2
SCHEMBL9224504 0.81 ALDH1A1 (0.46) SLC6A3SLC6A2RAB9ASIGMAR1ALDH1A1
SCHEMBL27306803 0.81 ALDH1A1 (0.49) SLC6A3SLC6A2RAB9AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0164853-B1 (SUBSTITUTED-PHENYL)-5-OXO-2-PYRROLIDINEPROPANOIC ACIDS, A PROCESS FOR PRODUCING THE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS WARNER-LAMBERT COMPANY (US) 1988-07-06 EP disclosed
US-4584313-A TREATING SENILITY WARNER-LAMBERT COMPANY (US) 1986-04-22 US disclosed
EP-0164853-A1 (substituted-phenyl)-5-oxo-2-pyrrolidinepropanoic acids, a process for producing the compounds and pharmaceutical compositions comprising the compounds WARNER-LAMBERT COMPANY (US) 1985-12-18 EP disclosed